Lyell Immunopharma Inc (NASDAQ: LYEL) is -14.88% lower on its value in year-to-date trading and has touched a low of $0.55 and a high of $3.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LYEL stock was last observed hovering at around $0.55 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.54, the stock is -6.87% and -19.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.22 million and changing -1.57% at the moment leaves the stock -61.28% off its SMA200. LYEL registered -68.14% loss for a year compared to 6-month loss of -64.39%. The firm has a 50-day simple moving average (SMA 50) of $0.68484 and a 200-day simple moving average (SMA200) of $1.41588.
The stock witnessed a -9.80% gain in the last 1 month and extending the period to 3 months gives it a -55.34%, and is -9.61% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.93% over the week and 8.11% over the month.
Lyell Immunopharma Inc (LYEL) has around 224 employees, a market worth around $159.17M and $0.06M in sales. Profit margin for the company is -323792.06%. Distance from 52-week low is -0.15% and -83.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-35.04%).
The EPS is expected to grow by 21.51% this year, but quarterly earnings will post -59.23% year-over-year. Quarterly sales are estimated to shrink -100.00% in year-over-year returns.
Lyell Immunopharma Inc (LYEL) Top Institutional Holders
155.0 institutions hold shares in Lyell Immunopharma Inc (LYEL), with institutional investors hold 67.62% of the company’s shares. The shares outstanding are 256.56M, and float is at 150.81M with Short Float at 8.22%. Institutions hold 58.53% of the Float.
The top institutional shareholder in the company is MWG MANAGEMENT LTD. with over 20.16 million shares valued at $29.24 million. The investor’s holdings represent 7.9301% of the LYEL Shares outstanding. As of 2024-06-30, the second largest holder is ORLAND PROPERTIES LTD with 15.09 million shares valued at $$21.89 million to account for 5.9366 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 13.5 million shares representing 5.3078% and valued at over $19.57 million, while VANGUARD GROUP INC holds 5.2697 of the shares totaling 13.4 million with a market value of $19.43 million.
Lyell Immunopharma Inc (LYEL) Insider Activity
#####
